Venous stasis ulcers (VSU) account for approximately 80-90% of lower extremity ulcerations.
Given their prevalence and chronic nature, VSU are thought to impose a significant economic burden on Medicare (the USA's largest health insurance program) and other third party payers.
However, comprehensive studies on the costs of VSU treatment are lacking.
The objective of this study therefore was to examine comprehensively the direct medical costs of treating patients with a VSU in routine clinical practice.
A cohort of 78 patients who presented with a VSU to the Cleveland Clinic Foundation (CCF), a large primary and tertiary referral center, was studied retrospectively.
All inpatient and outpatient costs related to VSU treatment that were incurred during the year following VSU presentation or until the ulcer healed, whichever occurred first, were quantified.
A total of 71 (91%) patients healed during the study.
The average duration of follow-up was 119 days (median : 84 days).
The average number of visits per patient was seven (range : 2 to 57).
A total of 14 (18%) patients underwent 18 hospitalizations for VSU care.
The average total medical cost per patient was S9685 (median : $3036).
Home health care, hospitalizations and home dressing changes accounted for 48%, 25% and 21% of total costs, respectively.
Total costs were related to duration of active therapy, ulcer size and the presence of at least one comorbidity (p<0.05). (...)
Mots-clés Pascal : Insuffisance veineuse, Ulcère, Jambe, Coût, Economie santé, Traitement, Homme, Membre inférieur, Appareil circulatoire pathologie, Vaisseau sanguin pathologie, Veine pathologie, Peau pathologie
Mots-clés Pascal anglais : Venous incompetence, Ulcer, Leg, Costs, Health economy, Treatment, Human, Lower limb, Cardiovascular disease, Vascular disease, Venous disease, Skin disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0196406
Code Inist : 002B12B03. Création : 16/11/1999.